Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any idea what he is being treated with?
Optimus, thanks but i dont think thats enough evidence that he will do anything. Besides any short attempt will be short lived as we are expecting HCV and AIDS data any minute. Personally, I will LOL knowing he is losing his 'shorts'.
That link only leads to his sight. Can you copy and paiste otherwise I am suspicious.
Would not want to be empty handed pre market monday morning. Huge news coming next week that will take this to new highs. Pennies will be history soon IMO.
AEMD Awaiting results for AIDS and HEP-C trials using the hemopurifier, a filter device that pulls viral pathogens out of the blood.
Has already been used to save the life of a Ugandan doctor in Frankfurt Germany who was suffering late stages of Ebola virus contracted while treating sufferers of the outbreak in Sierre Lione. Time magazine has just named the Hemopurifier to its 'Top 25 Inventions of 2014' list.
Results are due by the end of this month/ early December latest.
currently at .42
Who wants to make some money?
This is great exposure!
Gap on daily chart @ .33, gonna fill? It could in nest two days without news. HCV news soon, next week? GLTA
1.00 is cheap, .40 is a gift
When seconds count, why was Salia flown all the way to Nebraska in the US when Europe would have been a much faster trip? May have saved his life?
Salia has died, just heard
Hellos to you, welcome..
Only a matter of time before big pharma steps in and wants to 'talk'.
AEMD
Aethlon Medical (OTC:AEMD) has also enjoyed a longer-term uptrend. After falling to lows of $0.1025 in late September, the stock has rallied as much as 200% during the last 3 months. The company's work in the Ebola pandemic has sparked much more interest from the investment community. Aethlon specializes in "developing targeted therapeutic devices to address infectious disease" and one of its most recent reports on treatment data will be published this coming Friday at the American Society of Nephrology Annual Meeting. Beyond the Ebola virus, Aethlon will also utilize its Hemopurifier in the potential treatment of chronic viral pathogens such as HIV and Hepatitis C. So as speculation arises from what investors may see as potentially very positive results from this upcoming annual meeting, AEMD has enjoyed significant price appreciation during the first half of the month.
GLTA
They also have the DOD data
and 100 aids patients treated in India.
They have alot of data and there is much more going on here than ebola.
Agreed......for now, LOL
Shine it up any way you like, an RS is always an easy way out for lazy incompetent management. The SS at CVSL was NEVER a problem. 1/10 in 2011 and the cheerleaders kept pumping leading many to buy more and they were rewarded with another last month (not sure the ratio) wiping out more shares. Those who held through all of this have only a fraction of their shares and are lucky to break even on original investment. Do not fall in love with any of these companies, they have no love for you.
Having said that, I like the potential TO MAKE MONEY in PXYN until they take a turn for the lazy and incompetent as nearly all of them do at some point. GLTY
Not exactly the best example...
That company RS'd its way to an uplisting wiping out sharholders along the way. If PXYN uplists I hope they do it the old fashioned way with hard work, solid management, and solid revs. IMO
LOL!!
Aethlon and JJ need to make some noise here quickly so that the HP contribution to this patients recovery is not overshadowed by some pharma company pushing a drug that likely had little to do with it. Everything happens NOW. Tomorrow is too late.
So he was in advanced stages of the virus and our filter brought him back. He is very lucky to be alive!
Hopefully any later news release will include more details.
This can be news of the world or it can be dull and over looked, depending on details and how it is worded. The current tragedy in D.C. has been trying to downplay ebola going into yesterdays elections but they wont be able to keep it quiet any longer.
True, a reverse split is just part of the business plan for these 'paper pushers'. Your previous posts regarding the extra activities of certain directors in association with Scott Silverman should be sticky'd.
#17012, good info for anyone considering putting money in this fraud.
A tangled web indeed
LOL, I didnt bother going back any further than the first page.....
These deals are just the tip of the iceberg with these crooks.
Tommer, this is just the latest and 7th toxic funding arrangement this company has made since June. The real fun begins just in time for Christmas. This will never be .50... I will be shocked if it stays out of the tripzz.
I'll tell you why he gets angry........
Its just a dam thermometer and he is concerned about the slightly misleading nature of his public statements.
More toxic funding has been secured! enjoy
A tiny float and an AS$ the size of Texas!!
10Bils!
Aethlon is turning a corner now into new possibilities.
I just hope it isnt to far under the radar.
Who has made an offer?
Now that is worrisome! LOL
If this is current why are people worried about an RS???
SS looks perfect to me
Yes careful, yet bursting with positive implications between the lines!
Yep..and what is holding back an update here?
Rapid ebola test by end of October........
http://www.channelnewsasia.com/news/world/french-scientists-devise/1427872.html
If US companies are going to have any relevance at all the FDA will have to get out of the way.....
agreed sorry....satire should at least try to be humorous. Ebola is not humorous
"The Company divested two non-core assets in 2013, including its ownership in VeriTeQ Corporation for $750,000."
The government is funding the competition and the competition is being bought out and taken private. The acquisition, to be finalized this quarter, will most likely put their rapid diagnostic test on a fast track through European approval which is already much faster and less costly than the US FDA process.
Dont even get me started on PSIDs current love affair with notorious toxic loan sharks over the past 3 months and the tsunami of dilution that is sure to result in 2015.
Link not working here
"NATURAL BORN KILLER"??